Privia Health Group, Inc.
Close on Oct 19, 2026
- Market cap
- $2.96B
- P/E (TTM)
- 106.9
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | Before market open | $632.60M | $0.07 | $0.19 |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | Before market open | $603.80M | $0.02 | $0.19 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 26, 2026 | Before market open | $541.20M | $0.07 | $0.25 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | Before market open | $580.40M | $0.05 | $0.29 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | Before market open | $521.20M | $0.02 | $0.24 |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | Before market open | $480.10M | $0.03 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | Before market open | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | Before market open | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDA to convert to free cash flownon-GAAP | full-year 2026 | 70% to 80% | New |
| Attributed Livesnon-GAAP | full-year 2026 | 1,625,000 to 1,650,000 | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Privia Health filed with the SEC
Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports First Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
Other events · EX-99.1 to Form 8-K
Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase
Regulation FD disclosure · EX-99.1 to Form 8-K
Privia Health Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
J.P. Morgan 2025 Healthcare Conference January 2025 Investor Presentation
Regulation FD disclosure · EX-99.1 to Form 8-K
Privia Health Reports Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports Second Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Privia Health Reports First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Appoints Edward C. Fargis as General Counsel
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Privia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South Carolina
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports Second Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Reports First Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Privia Health Announces Leadership Succession
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Privia Health Reports Fourth Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K